Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model - Laboratoire Charles Friedel Accéder directement au contenu
Article Dans Une Revue International Journal of Pharmaceutics Année : 2009

Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model

Résumé

Ferrociphenol (Fc-diOH) is a new molecule belonging to the fast-growing family of organometallic anticancer drugs. In a previous study, we showed promising in vivo results obtained after the intratumoural subcutaneous administration of the new drug-carrier system Fc-diOH-LNCs on a 9L-glioma model. To further increase the dose of this lipophilic entity. we have created a series of prodrugs of Fc-diOH. The phenol groups were protected by either an acetyl (Fc-diAc) or by the long fatty-acid chain of a palmitate (Fc-diPal). LNCs loaded with Fc-diOH prodrugs have to be activated in situ by enzymatic hydrolysis. We show here that the protection of diphenol groups with palmitoyl results in the loss of Fc-diOH in vitro activity, probably due to a lack of in situ hydrolysis. On the contrary, protection with an acetate group does not affect the strong, in vitro, anti proliferative effect of ferrocifen-loaded-LNCs neither the reduction of tumour volume observed on an ectopic model, confirming that acetate is easily cleaved by cell hydrolases. Moreover, the cytostatic activity of Fc-diOH-LNCs is confirmed on an orthotopic glioma model since the difference in survival time between the infusion of 0.36 mg/rat Fc-diOH-LNCs and blank LNCs is statistically significant. By using LNCs or Labrafac (R) to carry the drug, a dose-effect ranging from 0.005 to 2.5 mg of Fc-diOH per animal can be evidenced.
Fichier principal
Vignette du fichier
Dose effect activity of ferrocifen.pdf (505.37 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01230396 , version 1 (28-05-2021)

Identifiants

Citer

E. Allard, N. T. Huynh, A. Vessières, Pascal Pigeon, G. Jaouen, et al.. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model. International Journal of Pharmaceutics, 2009, 379 (2), pp.317-323. ⟨10.1016/j.ijpharm.2009.05.031⟩. ⟨hal-01230396⟩
167 Consultations
93 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More